tel: +39 02 6444.7220
Niguarda is at the forefront of research for trials testing new therapies supported by international cooperation activities.
In recent years a positive trend in clinical trial has been observed, in neuroscience, diabetology, pain therapy, gene therapy, cardiovascular diseases, haematology, oncology, resulting in an improved scientific impact factor.
Niguarda is a public hospital dedicated to care; clinical research and knowledge-sharing are fully integrated in the hospital strategy.
The presence of professional skills, technological competences, certified laboratories and high complexity patient cohorts make Niguarda a unique and interesting partner for future cooperation.
It offers concrete opportunities to Pharma and Biotech Companies that are looking for a reliable and expert clinical/scientific partner.
The attitude to a real multidisciplinary approach offered to researcher makes Niguarda as a unique “one stop shop” for research and development.
The main strength point is the high volume of diagnostic/therapeutic activities that allows
an optimal integration between research and patient care, defining Niguarda as one of the best possible clinical sites for translational research.